Cargando…
Prevalence of Her3 in gastric cancer and its association with molecular prognostic markers: a Saudi cohort based study
Her 3 is a member of epidermal growth factor receptors. Mutated, oncogenic Her3 is reported in gastric and colonic cancers with emerging evidence that Her3 can be a potential target for molecular therapies. There is a paucity of studies regarding Her3 and its prognostic implications in gastric cance...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442113/ https://www.ncbi.nlm.nih.gov/pubmed/30915908 http://dx.doi.org/10.1080/19932820.2019.1574532 |